SHANGHAI, China, April. 20, 2023 - BioNova Pharmaceuticals Limited (BioNova), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to BN104 for the treatment of acute myeloid leukemia (AML).
2889 Jinke Road, Chamtime Plaza, Building B, 9F,
Suite 901 Shanghai 201203, China
Email : firstname.lastname@example.org